학술논문
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
Document Type
Article
Author
Source
In The Lancet Respiratory Medicine November 2017 5(11):891-902
Subject
Language
ISSN
2213-2600